Skip to main content
. 2017 Jul 20;7:6019. doi: 10.1038/s41598-017-06131-0

Figure 7.

Figure 7

(A) Protein crystallographic structural model of human NR3C1 (PDB ID: 1ZXM) with the co-crystallized inhibitor CV7 binding site (orange color sphere). (B) Binding site pocket residues with best fit confirmation of maslinic acid analog P-902 (yellow color). (C) Binding site pocket residues with docked maslinic acid analog P-902 (green color) and control drug CV7.